CONFIDENCE IN News

Buy Rating on Vertex Pharmaceuticals: Risinger's Confidence in VX-548's Billion-Dollar Potential and FDA Progress

TipRanksApr 22 01:16 ET

Buy Rating for Uber: Strong Growth and Share Buyback Signal Confidence in Expansion and Innovation

TipRanksApr 19 10:25 ET

Maintaining Buy Rating on Marinus Pharmaceuticals: Confidence in Research and Strategic Financial Health

TipRanksApr 15 13:25 ET

Mizuho Upgrades Ecolab to Buy From Neutral, Boosts Price Target to $260 From $216 on Greater Confidence in Earnings Visibility

MT NewswiresApr 12 06:09 ET

Intra-Cellular Therapies Buy Rating: High Confidence in Caplyta's Success for MDD Treatment

TipRanksApr 5 05:25 ET

Chardan Raises Price Target on Dyne Therapeutics to $31 From $20 on Increased Confidence in Lead Assets for DM1, DMD, Keeps Buy Rating

MT NewswiresMar 8 07:41 ET

Analyst Maintains Buy Rating on Twilio Citing Confidence in Strategic Decisions and Growth Prospects

TipRanksMar 8 06:45 ET

RBC Raises Price Target on FMC to $66 From $59 on Greater Confidence in FMC Meeting Forecasts, Keeps Outperform Rating

MT NewswiresMar 7 06:58 ET

Buy Rating Backed by Promising Developments and Regulatory Confidence in Inhibikase's Pipeline

TipRanksMar 5 10:45 ET

Buy Rating Affirmed for Cytokinetics as Camzyos Prescriptions Rise and Confidence in Dosing Grows

TipRanksFeb 13 05:19 ET

RBC Raises Price Target on Cloudflare to $108 From $95 on Increased Estimates, More Confidence in 2024; Outperform Kept

MT NewswiresFeb 9 06:39 ET

RBC Raises Price Target on Catalent to $58 From $55 on Increased Confidence in Achievability of Estimates; Outperform Kept

MT NewswiresJan 30 06:56 ET

RBC Lifts Price Target on Capital One Financial to $142 From $140, Encouraged by Management's Confidence in Outlook; Sector Perform Kept

MT NewswiresJan 26 07:33 ET

Morgan Stanley Lifts Price Target on Accenture to $400 From $369, Cites Confidence in 'Ability to Acquire Quality Assets at Attractive Valuations,' Keeps Overweight Rating

MT NewswiresJan 24 08:44 ET

Strong Buy Rating Affirmed for Pharvaris With Enhanced Confidence in Deucrictibant's HAE Program

TipRanksJan 22 17:45 ET

RBC Raises Price Target on Varonis Systems to $52 From $40 on Increased Confidence in Model Transition, Keeps Outperform Rating

MT NewswiresDec 4, 2023 08:23 ET

Maintaining Buy Rating on Argenx Se Despite ITP Trial Miss: Confidence in Vyvgart's Potential and Broader Market Opportunity

TipRanksNov 29, 2023 08:35 ET

Maintaining Buy Rating on Argenx: Confidence in Efgartigimod's Prospects Despite Phase 3 Setback

TipRanksNov 28, 2023 12:15 ET

GoDaddy Upgraded by RBC to Outperform From Sector Perform, Price Target Raised to $124 From $90 Amid 'Rising Confidence in Margin Expansion'

MT NewswiresNov 22, 2023 07:55 ET

Unwavering Confidence in Avita Medical's Future Profitability: A Buy Recommendation Despite Temporary Approval Setbacks

TipRanksNov 21, 2023 09:15 ET